Expired Tender Czech Republic ICB TOT Ref. 145980240

Lp for Auologic Cell Therapy - Ciltakabtagen Tender - 145980240

Tender notice from Czech Republic, published on 27 Jul 2026.

Executive Summary

The UNIVERSITY HOSPITAL PILSEN has issued a Tender notice for the procurement of a Lp for Auologic Cell Therapy - Ciltakabtagen Autoleucel - 2026 in the Czech Republic. This Tender notice was published on 27 Jul 2026 and is scheduled to close on 25 Aug 2026, with an estimated Tender value of CZK 297935907. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 145980240, while the tender notice number is 515909-2026 and Register on the platform.

Key facts

Summary
Lp for Auologic Cell Therapy - Ciltakabtagen Autoleucel - 2026
TOT Ref. No.
145980240
Document Ref. No.
515909-2026
Country
Czech Republic
Notice type
Tender
Competition
ICB
Publication date
27 Jul 2026
Bid deadline
25 Aug 2026
EMD
Refer Document
Tender value
CZK 297935907
Purchaser ownership
Public
Procurement Type
Goods
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

cytostatic drug for CAR-T therapy - ciltakabtagen autoleucel The subject of the public contract is the supply of a medicinal product intended for the therapy of malignant blood diseases in the total expected volume of 30 individual doses of the medicinal product. The preparation is intended for provision of health care at the medical workplace of the FN Plzeň. Deliveries of the subject of performance will be carried out on the basis of the results of the completed procurement procedure for a period of three years from the signing of the purchase contract. Cytostatic drug for CAR-T therapy (ciltakabtagen autoleucel) - infusion bag containing a cell dispersion of 3.2x10⁶ to 1x10⁸ viable anti-BCMA CAR-positive T-lymphocytes. The expected annual volume is 10 infusion bags containing an individually determined amount of the active ingredient, ATC L01XL05 A dose means an infusion bag for a one-time application containing a specified active ingredient in an amount determined individually according to the needs of a specific patient. The medicinal product offered must meet the requirements of SÚKL. SÚKL registration is a necessary condition for standard use medicinal products within the provision of health care according to § 8 paragraph 1 of Act No. 378/2007 Coll., on medicinal products. Fulfillment of this condition is documented by the participant by indicating the valid SÚKL code of the medicinal product offered in the relevant column of the table for supplementing the offer price, which is the content of Annex No. 1 of the tender documentation (see point 9.2.). The medicinal product is intended for the treatment of adult patients with relapsed and refractory multiple myeloma who have undergone at least...
Document Type: Contract Notice Reference Number: 23/26 Contract Type: supplies Estimated Value: 297935907 - CZK Authority Type: body-pl-cga Doc Title: LP pro auologní buněčnou terapii - ciltakabtagen autoleucel - 2026 Dispatch Date: 2026-07-24 Publish Date: 2026-07-27 Submission Date: 2026-08-25

Documents

Tender Notice
Login to view

Corresponding contract award notice

Similar tenders

Tender Country TOT Ref. No. Bid deadline
Medicinal Product of Atc Group L04ac24 with the Active Substance Mirikizumab Czech Republic 152647180 18 Dec 2026
Medicinal Product of Atc Group L03ab13 with the Active Ingredient Peginterferon Beta-1A Czech Republic 152644383 18 Dec 2026
Medicinal Product of Atc Group R03dx10 with the Active Substance Benralizumab Czech Republic 152641430 18 Dec 2026
Medicinal Product of Atc Group S01ba01 with the Active Substance Dexamethason Czech Republic 152641319 18 Dec 2026
Accessories for Pipettes Czech Republic 152607428 23 Nov 2026

Czech Republic Public Procurement Intelligence

Frequently asked questions

The bid deadline for Lp for Auologic Cell Therapy - Ciltakabtagen Autoleucel - 2026 was 25 Aug 2026. Bidding is closed.

This tender has been issued by UNIVERSITY HOSPITAL PILSEN in Czech Republic.

The estimated tender value is CZK 297935907. EMD / bid security details are provided in the tender document.

This tender is Self Financed

This is a Goods procurement tender issued as a public sector opportunity in Czech Republic.

The tender is classified under the following CPV code(s): 33652000 - Antineoplastic and immunomodulating agents.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 145980240. The purchaser document reference is 515909-2026.

See the Similar Tenders section on this page or browse other tenders from Czech Republic.

This tender falls under Materials and Products, Technology and Equipment in Czech Republic. Suppliers in these sectors can track similar Czech Republic tenders using CPV-based alerts.